WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 35 filers reported holding WEREWOLF THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $17,000 | – | 3,946 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 589,102 | $1,207,659 | 32.70% |
| MPM ASSET MANAGEMENT LLC | 4,284,172 | $8,782,553 | 3.68% |
| MPM BioImpact LLC | 2,388,011 | $4,895,423 | 1.27% |
| SPHERA FUNDS MANAGEMENT LTD. | 626,810 | $1,284,961 | 0.28% |
| RA Capital Management | 4,291,881 | $8,798,356 | 0.18% |
| Rubric Capital Management LP | 1,835,387 | $3,762,543 | 0.16% |
| Tejara Capital Ltd | 128,800 | $264,040 | 0.15% |
| Oasis Management Co Ltd. | 246,305 | $504,925 | 0.10% |
| PFM Health Sciences, LP | 1,293,293 | $2,651,251 | 0.10% |
| Laurion Capital Management LP | 522,900 | $1,071,945 | 0.01% |